Alzheimer's and Dementia: Translational Research and Clinical Interventions

ESCI-ISI SCOPUS (2015-2025)

  2352-8737

 

  Mỹ

 

Cơ quản chủ quản:  WILEY , John Wiley & Sons Inc.

Lĩnh vực:
Psychiatry and Mental HealthNeurology (clinical)

Phân tích ảnh hưởng

Các bài báo tiêu biểu

Inflammation as a central mechanism in Alzheimer's disease
Tập 4 Số 1 - Trang 575-590 - 2018
Jefferson W. Kinney, Shane M. Bemiller, Andrew S. Murtishaw, Amanda M. Leisgang, Arnold Salazar, Bruce T. Lamb
AbstractAlzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD. The sustained activation of the brain's resident macrophages (micro... hiện toàn bộ
Alzheimer's disease drug development pipeline: 2018
Tập 4 Số 1 - Trang 195-214 - 2018
Jeffrey L. Cummings, Garam Lee, Aaron Ritter, Kate Zhong
AbstractIntroductionTreatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD. Drug development for AD therapies can be examined by inspecting the drug development pipeline as represented on clinicaltrials.gov.MethodsClinicaltrials.gov was assessed as of January 30, 2018 to determine AD therapies represented in... hiện toàn bộ
Alzheimer's disease drug development pipeline: 2017
Tập 3 Số 3 - Trang 367-384 - 2017
Jeffrey L. Cummings, Garam Lee, Travis Mortsdorf, Aaron Ritter, Kate Zhong
AbstractIntroductionThere is an urgent need to develop new treatments for Alzheimer's disease (AD) and to understand the drug development process for new AD therapies.MethodsWe assessed the agents in the AD pipeline as documented in clinicaltrials.gov for phase I, phase II, and phase III, accessed 1/5/2017.ResultsThere are 105 agents in the AD treatment development pipeline, of which 25 agents are... hiện toàn bộ
Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health
Tập 3 Số 3 - Trang 291-300 - 2017
Michael J. Wheeler, Paddy C. Dempsey, Megan S. Grace, Kathryn A. Ellis, Paul A. Gardiner, Daniel J. Green, David W. Dunstan
AbstractCognitive decline leading to dementia represents a global health burden. In the absence of targeted pharmacotherapy, lifestyle approaches remain the best option for slowing the onset of dementia. However, older adults spend very little time doing moderate to vigorous exercise and spend a majority of time in sedentary behavior. Sedentary behavior has been linked to poor glycemic control and... hiện toàn bộ
Amyloid‐associated increases in longitudinal report of subjective cognitive complaints
Tập 4 - Trang 444-449 - 2018
Rebecca E. Amariglio, Rachel F. Buckley, Elizabeth C. Mormino, Gad A. Marshall, Keith A. Johnson, Dorene M. Rentz, Reisa A. Sperling
AbstractIntroductionTo investigate whether baseline subjective cognitive complaints (SCCs) predict longitudinal decline on neuropsychological testing and whether SCC increases longitudinally, in the setting of high levels of amyloid burden.MethodsTwo hundred seventy‐nine clinically normal older participants (mean age = 73.7 ± 6.1 years) from the Harvard Aging Brain Study, a cohort of community‐dwe... hiện toàn bộ
Accelerating drug development for Alzheimer's disease through the use of data standards
Tập 3 - Trang 273-283 - 2017
Jon Neville, Steve Kopko, Klaus Romero, Brian Corrigan, Bob Stafford, Elizabeth LeRoy, Steve Broadbent, Martin Cisneroz, Ethan Wilson, Eric Reiman, Hugo Vanderstichele, Stephen P. Arnerić, Diane Stephenson
AbstractIntroductionThe exceedingly high rate of failed trials in Alzheimer's disease (AD) calls for immediate attention to improve efficiencies and learning from past, ongoing, and future trials. Accurate, highly rigorous standardized data are at the core of meaningful scientific research. Data standards allow for proper integration of clinical data sets and represent the essential foundation for... hiện toàn bộ
Tolerability of ORM‐12741 and effects on episodic memory in patients with Alzheimer's disease
Tập 3 - Trang 1-9 - 2017
Juha O. Rinne, Keith Wesnes, Jeffrey L. Cummings, Pasi Hakulinen, Merja Hallikainen, Jutta Hänninen, Michael Murphy, Henry Riordan, Mika Scheinin, Hilkka Soininen, Juha Rouru
AbstractIntroductionORM‐12741 is a novel selective antagonist of alpha‐2C adrenoceptors. This trial evaluated the safety and efficacy of ORM‐12741 in patients with Alzheimer's disease (AD).MethodsA randomized, double‐blind, placebo‐controlled, exploratory phase 2a trial was conducted in 100 subjects with AD and neuropsychiatric symptoms. Participants were randomized to receive one of two flexible ... hiện toàn bộ
TOMMORROW neuropsychological battery: German language validation and normative study
Tập 4 - Trang 314-323 - 2018
Heather R. Romero, Andreas U. Monsch, Kathleen M. Hayden, Brenda L. Plassman, Alexandra S. Atkins, Richard S.E. Keefe, Shyama Brewster, Carl Chiang, Janet O'Neil, Grant Runyan, Mark J. Atkinson, Stephen Crawford, Kumar Budur, Daniel K. Burns, Kathleen A. Welsh-Bohmer
AbstractIntroductionAssessment of preclinical Alzheimer's disease (AD) requires reliable and validated methods to detect subtle cognitive changes. The battery of standardized cognitive assessments that is used for diagnostic criteria for mild cognitive impairment due to AD in the TOMMORROW study have only been fully validated in English‐speaking countries. We conducted a validation and normative s... hiện toàn bộ
Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease
Tập 2 - Trang 182-191 - 2016
Virginia Boccardi, Marta Baroni, Francesca Mangialasche, Patrizia Mecocci
AbstractIntroductionVitamin E family, composed by tocopherols and tocotrienols, is a group of compounds with neuroprotective properties. The exact role in the pathogenesis and the benefit of vitamin E as treatment for Alzheimer's disease (AD) are still under debate.MethodsA literature search in PubMed, Medline, and Cochrane databases has been carried out. All types of studies, from bench and anima... hiện toàn bộ
The Brain Health Champion study: Health coaching changes behaviors in patients with cognitive impairment
Tập 5 - Trang 771-779 - 2019
Hope E.M. Schwartz, Camden P. Bay, Brittany M. McFeeley, Taylor J. Krivanek, Kirk R. Daffner, Seth A. Gale
AbstractIntroductionConverging evidence suggests that increasing healthy behaviors may slow or prevent cognitive decline.MethodsWe piloted a six‐month, randomized, controlled investigation of 40 patients with mild dementia, mild cognitive impairment, or subjective cognitive decline. The intervention consisted of weekly motivational interviewing phone calls and three visits with a “Brain Health Cha... hiện toàn bộ